Table 3

Factors associated with achievement of BP targets in people on antihypertensive medication
Univariate odds ratios of achieving NICE BP targets Multivariable odds ratios of achieving NICE BP target ∞ Univariate odds ratios of achieving KDOQI BP targets Multivariable odds ratios of achieving KDOQI BP target † Univariate odds ratios of achieving KDIGO BP targets Multivariable odds ratios of achieving KDIGO BP target ∞
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Sex (compared to female) Male 0.91 (0.73,1.12) 0.359 0.88 (0.71,1.10) 0.260 0.80 (0.64,1.00) 0.050 0.76 (0.60,0.96) 0.023 0.75 (0.61,0.93) 0.009 0.93 (0.74,1.18) 0.56
Age (compared to <60 age group) 60-69 0.60 (0.36,1.03) <0.001 0.43 (0.26,0.71) <0.001 0.73 (0.46, 1.18) 0.155 0.66 (0.41,1.08) 0.002 0.66 (0.39,1.12) 0.001 0.51 (0.29,0.89) <0.001
70-79 0.43 (0.26,0.71) 0.27 (0.17,0.43) 0.64 (0.41,1.01) 0.49 (0.31,0.79) 0.52 (0.32,0.87) 0.34 (0.20,0.58)
80+ 0.35 (0.21,0.59) 0.21 (0.13,0.35) 0.60 (0.38, 0.97) 0.43 (0.26,0.72) 0.41 (0.24,0.68) 0.27 (0.15,0.48)
Diabetes (compared to people without diabetes) People with diabetes 0.36 (0.28,0.47) <0.001 0.32 (0.25,0.43) <0.001 1.12 (0.86,1.17) 0.410 1.08 (0.81,1.43) 0.601 0.97 (0.74,1.26) 0.796 1.14 (0.85,1.53) 0.38
Albuminuria (compared to no albuminuria) People with albuminuria 0.54 (0.41,0.72) <0.001 0.56 (0.42,0.74) 0.001 0.70 (0.52, 0.95) 0.021 0.65 (0.47,0.90) 0.009 0.70 (0.52,0.95) 0.021 0.21 (0.16,0.30) <0.001
History of CVD (compared to people with no CVD) People with CVD 1.41 (1.13,1.76) 0.002 1.87 (1.49,2.35) <0.001 1.66 (1.33,2.07) <0.001 1.89 (1.49,2.39) <0.001 1.42 (1.14,1.77) 0.002 1.83 (1.43,2.34) <0.001
eGFR (compared to 45–59) 60+ 1.03 (0.81,1.31) 0.001 0.84 (0.65, 1.09) 0.088 0.78 (0.62,1.00) 0.145 - - 0.97 (0.74,1.28) 0.004 0.83 (0.62,1.11) 0.27
<45 0.66 (0.52, 0.83) 0.77 (0.60, 0.99) 0.92 (0.72, 1.17) 0.66 (0.52,0.85) 0.83 (0.64, 1.09)

∞ Model adjusted for age, sex, albuminuria, diabetes, CVD, and eGFR.

† Model adjusted for age, sex, albuminuria, diabetes, and CVD.

Abbreviations:

BP blood pressure.

RAASi renin-angiotensin aldosterone system inhibitors.

NICE National Institute for Health and Clinical Excellence.

KDOQI National Kidney Foundation Kidney Disease Outcome Quality Initiative.

CVD cardiovascular disease.

eGFR estimated Glomerular Filtration Rate.

Fraser et al.

Fraser et al. BMC Family Practice 2013 14:88   doi:10.1186/1471-2296-14-88

Open Data